Concepedia

Publication | Open Access

CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1

50

Citations

27

References

2022

Year

Abstract

Our data demonstrate that YBX1/CTPS1 axis plays an important role in the progression of TNBC. CTPS1 might be a promising prognosis biomarker and potential therapeutic target for patients with triple-negative breast cancer.

References

YearCitations

Page 1